Company: VEEAW
Filing Date: 2025-07-07
Form Type: DRS
Source: 0001213900-25-061586
Chunk: 179

Company: VEEA INC.
Filing Date: 2025-07-07
Form: DRS
Chunk 179
---
 be issued as individual warrant agreements to the investors. You should review the form of common warrant, filed as an
exhibit to the registration statement of which this prospectus forms a part, for a complete description of the terms and conditions applicable
to the common warrant.

Exercisability.
The common warrant will be exercisable, at the option of each holder, in whole or in part, by delivering to us a duly executed exercise
notice accompanied by payment in full in immediately available funds for the number of shares of our common stock purchased upon such
exercise (except in the case of a cashless exercise as described below). A holder (together with its affiliates) may not exercise any
portion of the common warrant to the extent that the holder would own more than 4.99% (or, at the election of the holder, 9.99%) of the
outstanding common stock immediately after exercise, except that upon at least 61 days’ prior notice from the holder to us, the
holder may increase the amount of ownership of outstanding stock after exercising the holder’s common warrants up to 9.99% of the
number of shares of our common stock outstanding immediately after giving effect to the exercise, as such percentage ownership is determined
in accordance with the terms of the common warrants. Purchasers of common warrants in this offering may also elect prior to the issuance
of the common warrants to have the initial exercise limitation set at 9.99% of our outstanding common stock. No fractional shares of
common stock will be issued in connection with the exercise of a common warrants. In lieu of fractional shares, we will pay the holder
an amount in cash equal to the fractional amount multiplied by the exercise price.

Duration and Exercise Price. The assumed exercise price per whole share of our common stock purchasable upon the exercise of the common warrants is
$[__] per share of common stock (or 100% of the assumed offering price per share and accompanying common warrants). The common warrants
will be exercisable beginning on the effective date of the Warrant Stockholder Approval, provided however, if the Pricing Conditions
are met, the Warrant Stockholder Approval will not be required and the common warrants will be exercisable on the Initial Exercise Date.
The common warrants will expire five years from the Initial Exercise Date or the Warrant Stockholder Approval, as applicable. The exercise
price of the common warrants is subject to appropriate adjustment in the event of certain stock dividends and distributions, stock splits,
stock combinations